101 related articles for article (PubMed ID: 1664434)
1. Modified tetrazolium-based colorimetric method for determining the activities of anti-HIV compounds.
Ayisi NK; Gupta SV; Qualtiere LF
J Virol Methods; 1991 Aug; 33(3):335-44. PubMed ID: 1664434
[TBL] [Abstract][Full Text] [Related]
2. Differential cytopathicity and susceptibility of Ghanaian highly divergent HIV-2 -GH2-, prototype HIV-2 -GH1-, and prototype HIV-1 -GH3- to inhibition by ddCyd and ddIno.
Ayisi NK
East Afr Med J; 1995 Oct; 72(10):654-7. PubMed ID: 8904046
[TBL] [Abstract][Full Text] [Related]
3. Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds.
Pauwels R; Balzarini J; Baba M; Snoeck R; Schols D; Herdewijn P; Desmyter J; De Clercq E
J Virol Methods; 1988 Aug; 20(4):309-21. PubMed ID: 2460479
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of human immunodeficiency virus in vitro by combinations of 3'-azido-3'-deoxythymidine and foscarnet.
Koshida R; Vrang L; Gilljam G; Harmenberg J; Oberg B; Wahren B
Antimicrob Agents Chemother; 1989 May; 33(5):778-80. PubMed ID: 2526616
[TBL] [Abstract][Full Text] [Related]
5. Synergistic inhibition of human immunodeficiency virus isolates (including 3'-azido-3'-deoxythymidine-resistant isolates) by foscarnet in combination with 2',3'-dideoxyinosine or 2',3'-dideoxycytidine.
Palmer S; Harmenberg J; Cox S
Antimicrob Agents Chemother; 1996 May; 40(5):1285-8. PubMed ID: 8723486
[TBL] [Abstract][Full Text] [Related]
6. In vitro anti-HIV-1 activity of sn-2-substituted 1-O-octadecyl-sn-glycero-3-phosphonoformate analogues and synergy with zidovudine.
Hostetler KY; Hammond JL; Kini GD; Hostetler SE; Beadle JR; Aldern KA; Chou TC; Richman DD; Mellors JW
Antivir Chem Chemother; 2000 May; 11(3):213-9. PubMed ID: 10901292
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationships of fluorinated nucleoside analogs and their synergistic effect in combination with phosphonoformate against human immunodeficiency virus type 1.
Koshida R; Cox S; Harmenberg J; Gilljam G; Wahren B
Antimicrob Agents Chemother; 1989 Dec; 33(12):2083-8. PubMed ID: 2533474
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and in vitro activity of long-chain 5'-O-[(alkoxycarbonyl)phosphinyl]-3'-azido-3'-deoxythymidines against wild-type and AZT- and foscarnet-resistant strains of HIV-1.
Rosowsky A; Fu H; Pai N; Mellors J; Richman DD; Hostetler KY
J Med Chem; 1997 Aug; 40(16):2482-90. PubMed ID: 9258355
[TBL] [Abstract][Full Text] [Related]
9. [Reverse transcriptase inhibitors as anti-HIV agents].
Shirasaka T; Mitsuya H
Nihon Rinsho; 1993 Sep; 51 Suppl():192-9. PubMed ID: 7505846
[No Abstract] [Full Text] [Related]
10. Inhibition of human immunodeficiency virus type 1 replication by phosphonoformate- and phosphonoacetate-2',3'-dideoxy-3'-thiacytidine conjugates.
Charvet AS; Camplo M; Faury P; Graciet JC; Mourier N; Chermann JC; Kraus JL
J Med Chem; 1994 Jul; 37(14):2216-23. PubMed ID: 8035429
[TBL] [Abstract][Full Text] [Related]
11. [Is resistance of human immunodeficiency viruses (HIV) to nucleoside analogs an indication for their combined use?].
Pépin JM; Simon F; Brun-Vezinet F
Pathol Biol (Paris); 1993 Oct; 41(8 Pt 2):788-93. PubMed ID: 8309722
[TBL] [Abstract][Full Text] [Related]
12. Resistance of human immunodeficiency virus type 1 to antiretroviral agents: a review.
Erice A; Balfour HH
Clin Infect Dis; 1994 Feb; 18(2):149-56. PubMed ID: 7512829
[No Abstract] [Full Text] [Related]
13. In vitro anti-human immunodeficiency virus activity of 2',3'-dideoxynucleosides and their effect on clonal growth of hemopoietic cells from human bone marrow.
Cinatl J; Cinatl J; Rabenau H; Gümbel H; Doerr HW
Arzneimittelforschung; 1993 May; 43(5):622-5. PubMed ID: 8329011
[TBL] [Abstract][Full Text] [Related]
14. Suppression of HIV production in resting lymphocytes by combining didanosine and hydroxamate compounds.
Malley SD; Grange JM; Hamedi-Sangsari F; Vila JR
Lancet; 1994 May; 343(8908):1292. PubMed ID: 7910296
[No Abstract] [Full Text] [Related]
15. The characterization of EIAV reverse transcriptase and its inhibition by 5'-triphosphates of 2'-deoxyuridine analogs, PFA and PAA.
Tao P; Zhang X; Quan K
Proc Chin Acad Med Sci Peking Union Med Coll; 1990; 5(3):130-4. PubMed ID: 1711694
[TBL] [Abstract][Full Text] [Related]
16. Anti-angiogenesis agent DS-4152 is a potent and selective inhibitor of HIV-1 replication in vitro.
Baba M; Shigeta S; Ikeuchi T; Korenaga H; Osada Y
AIDS; 1994 Jan; 8(1):43-8. PubMed ID: 7516666
[TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibility of clinical isolates of HIV-1 to XM323, a non-peptidyl HIV protease inhibitor.
Winslow DL; Mayers D; Scarnati H; Lane J; Bincsik A; Otto MJ
AIDS; 1994 Jun; 8(6):753-6. PubMed ID: 8086132
[TBL] [Abstract][Full Text] [Related]
18. Tetrazolium-based colorimetric assay for the detection of HIV replication inhibitors: revisited 20 years later.
Pannecouque C; Daelemans D; De Clercq E
Nat Protoc; 2008; 3(3):427-34. PubMed ID: 18323814
[TBL] [Abstract][Full Text] [Related]
19. Uncharged AZT and D4T derivatives of phosphonoformic and phosphonoacetic acids as anti-HIV pronucleosides.
Shirokova EA; Jasko MV; Khandazhinskaya AL; Ivanov AV; Yanvarev DV; Skoblov YS; Mitkevich VA; Bocharov EV; Pronyaeva TR; Fedyuk NV; Kukhanova MK; Pokrovsky AG
J Med Chem; 2004 Jul; 47(14):3606-14. PubMed ID: 15214788
[TBL] [Abstract][Full Text] [Related]
20. 2',3'-Dideoxycytidine toxicity in cultured human CEM T lymphoblasts: effects of combination with 3'-azido-3'-deoxythymidine and thymidine.
Törnevik Y; Eriksson S
Mol Pharmacol; 1990 Aug; 38(2):237-43. PubMed ID: 2166904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
